Roche

Key Dates

April 2011
Registration open

Early December 2011
Call for Late Breaking Abstracts

31 January 2012
Early Bird Registration Deadline

17 February 2012
Author registration deadline

25 - 29 March 2012
Symposium dates

Hosted By

The Australian Atherosclerosis Society

Call for Late Breaking Abstracts

Late Breaking Abstracts

The ISA2012 Scientific Program Committee invites the submission of Late Breaking Abstracts. Late Breaking Abstracts will generally be allocated a poster presentation. However, original work that is considered of an especially high standard and importance to the Symposium content will be considered for an oral/mini-oral presentation.

All successful abstracts will be published on a USB to be given to the Symposium delegates, and will be published on the ISA2012 website. Presenting authors must be registrants at the Symposium. All abstracts must be submitted online via the Symposium website using the online submission form.

Late Breaking Abstract Submission Form

Critical Dates

Late Breaking Abstract Submission Deadline
Friday 13 January 2012

Early Bird Registration Deadline
Tuesday 31 January 2012

Author Registration Deadline
Tuesday 17 February 2012

Travel Grants and Awards

IAS Early Career Poster Awards

The IAS will be offering 10 Best Poster Awards for Early Career Investigators (up to 10 years postdoctoral) at ISA2012. Payment will be available at the meeting. Please indicate on your abstract submission form if you would like to be considered for an Early Career Poster Award. Awards are not transferrable. Finalists will be asked to provide proof of graduation date and a CV.

Young Investigator Oral Award

The Australian Atherosclerosis Society (AAS) will be offering 10 Best Oral Awards for Young Investigators (up to 10 years postdoctoral) at ISA2012. Payment will be available at the meeting. Please indicate on your abstract submission form if you would like to be considered for an Young Investigator Oral Award. Awards are not transferrable. Finalists will be asked to provide proof of graduation date and a CV.

IAS Asia Pacific Regional Federation Education Grants
NOW CLOSED

The Asian Pacific Society of Atherosclerosis and Vascular Diseases (APSAVD) Education Grants
NOW CLOSED

Presentation Methods

During online abstract submission, authors will be requested to select their preferred method of presentation at the Symposium.

Please note: the oral presentation program space is limited. Abstracts from the first round of submission will receive precedence.

Oral Presentation: 10 minute oral presentation (plus 5 minutes question time) within a concurrent session.
Mini-Oral Presentation: 8 minute mini-oral presentation (plus 2 minutes question time). Presentations to be made during delegate lunch breaks within a mini-oral booth in the exhibition.
Poster Presentation: 1m x 1m hard copy poster, to be displayed in the exhibition hall.

Presentation method preferences will be taken into account during the review and program development process.

Late-Breaking Abstract Submission Instructions

Please read through the submission instructions below before preparing your abstract.

Step 1: Read the General Policies and Requirements for the submission of abstracts.
Step 2: Write your abstract, following the Abstract Guidelines.
Step 3: Select which Theme best relates to your abstract.
Step 4: Review the Evaluation Criteria and Review Process for abstracts.
Step 5: Download the Abstract Template and insert/add your abstract text. Save as a Microsoft Word document on your computer. Abstracts must not exceed 250 words.
Step 6: Click the button below to complete the Abstract Submission Form. It will be necessary to attach/upload the Microsoft Word copy of your abstract.
Step 7: Register to attend the Symposium by 9 December 2011.

General Policies and Requirements for the Submission of Late-Breaking Abstracts

All abstracts must contain original work that has not previously been reported
All abstracts must be prepared according to the guidelines provided. Submissions will be returned to the author without review if not in the correct format and must be resubmitted immediately in the correct format to be reviewed and considered for inclusion in the program.
The presenting author only must submit the abstract.
The presenting author will be required to register and pay for the conference to ensure their abstract(s) are included in the final program and abstract publication. Deadline for author registration is 17 February 2012.
Do not resubmit an abstract for any reason other than a notified submission error.
It is the responsibility of the presenting author to ensure that the abstract is submitted correctly. After an author has submitted their abstract, they must check their submission, which will be converted to a PDF file, to ensure the document has been uploaded correctly.
Abstracts will be reviewed by the appointed Symposium abstract reviewers.
Faxed or mailed hard-copy abstracts or abstracts sent on disc/CD will not be accepted. If you are unable to submit via the website, please contact the Symposium Organisers:

Phone: +61 2 9265 0700
Fax: +61 2 9267 5443
Email: isa2012@arinex.com.au

Disclaimer

The Symposium Organisers will not be held responsible for abstract submissions not received via the website or for submission errors caused by internet service outages, hardware or software delays, power outages or unforeseen events.

Abstract Guidelines

Abstract Content Guidelines

Abstracts must be submitted using the Microsoft Word template provided on the Symposium website.
Abstracts should take the form of a paragraph of 250 words. Abstracts exceeding the word limit will be returned for resubmission.
Abstracts must be submitted in clear English with accurate grammar and spelling of a quality suitable for publication.
The abstract should state the problem being addressed, the purpose of the paper, basic procedures/methods, main findings and principle conclusions. If necessary, references should be minimally cited in the body of the abstract.
A small number of graphs and tables may be included in the abstract, provided they add value to the content and remain within the bounds of the template.
Any funding support for research should be stated at the end.

Abstract Format Guidelines

The purpose of the abstract is to define the precise subject of the presentation to an audience.

Title
The abstract title should be short, informative and contain major key words. It should be in sentence case, bold, and left and right justified.

Authors
Abstract titles should be followed by authors’ first names and surnames (with the presenting author in bold) with superscript numbers for institution. Corresponding to these numbers, names of institutions should follow, including city, state and country (in this order). Do not include degrees or professional titles (e.g. Dr, Prof, etc,).

Example below:
Barry Smith¹, Penny Jones^1,2, Jeffrey Woods²
¹University of Sydney, Sydney, NSW, Australia
²University of Queensland, St Lucia, QLD, Australia

Text

Abstract text must be Times New Roman, 12 point font size, single-spaced and left and right justified.
Leave a line between sections but do not indent.
Use standard abbreviations only. Within the body of the abstract, when using abbreviations spell out the name in full at the first mention and follow with the abbreviation in the parenthesis. Abbreviations may be used in the title, provided the name in full is outlined in the body of the abstract.

Compliance to the specifications is imperative. Any abstract that does not comply with these specifications will not be accepted for review and will be returned to you by the Symposium Organisers for resubmission.

Abstract Themes

Abstract authors will be required to indicate which Theme best matches the content of their abstract. Themes for ISA2012 are:

Atherosclerosis and the immune system
Diabetes, insulin resistance and atherosclerosis
Epidemiology and the emergence of atherosclerosis in developing countries
Genetic and genomic approaches for identifying new therapeutic targets and risk factors
Gene therapy and atherosclerosis
HDL function and therapeutic strategies for raising HDL levels
Imaging in atherosclerosis
Mechanistic aspects of atherosclerosis
New insights into lipoprotein metabolism
New risk factors and biomarkers in atherosclerosis: lipidomic and proteomic approaches
New therapeutic approaches for treating atherosclerosis
Pharmacogenomics of atherosclerotic disease
Recent advances in nutrition, nutrigenomics and nutraceuticals
Vascular biology of atherosclerosis
Visceral obesity, metabolic syndrome and atherosclerosis

Evaluation Criteria and Review Process

Abstracts will be independently reviewed and scored by several reviewers in August/September 2011, using the following criteria:

Clearly written
Internally consistent
Indicates aims or hypothesis of the research/paper
Describes appropriate methods/methodology
Describes relevant results
Draws valid conclusions from the results
Is relevant to the Symposium audience

Reviewer scores and comments will be strongly considered when developing the Symposium program and offering presentation slots.

Abstract Embargo

The accepted abstracts are made available to the public on the ISA2012 website in advance of the Symposium. Thus, the first release of the abstracts is a public release. Coverage of additional research being presented at ISA2012 is under embargo until the date of presentation.

Academic institutions, private organisations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an abstract. However, ISA2012 continues to require that information that goes beyond that contained in the abstract (e.g. discussion of the abstract done as part of a scientific presentation) is to be embargoed until the start of the scientific sessions. Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Journalists failing to abide by the embargo may have their press credentials revoked.

ISA 2012